Literature DB >> 21233317

SNP rs6457327 in the HLA region on chromosome 6p is predictive of the transformation of follicular lymphoma.

David Wrench1, Pamela Leighton, Christine F Skibola, Lucia Conde, Jean-Baptiste Cazier, Janet Matthews, Sameena Iqbal, Emanuela Carlotti, Csaba Bödör, Silvia Montoto, Maria Calaminici, John G Gribben, T Andrew Lister, Jude Fitzgibbon.   

Abstract

Inherited risk determinants for follicular lymphoma (FL) have recently been described in the immune gene-rich human leukocyte antigen region on chromosome 6p. The known importance of host immune response to FL survival led us to evaluate these germline factors in FL outcome. We confirm the association of single nucleotide polymorphisms rs10484561 (P = 3.5 × 10⁻⁹) and rs6457327 (P = .008) with risk of FL and demonstrate that rs6457327 predicts both time to (P = .02) and risk of (P < .01) FL transformation independently of clinical variables, including the Follicular Lymphoma International Prognostic Index.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21233317      PMCID： PMC3062316          DOI： 10.1182/blood-2010-10-315382

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


  19 in total

1.  Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival.

Authors:  James R Cerhan; Sophia Wang; Matthew J Maurer; Stephen M Ansell; Susan M Geyer; Wendy Cozen; Lindsay M Morton; Scott Davis; Richard K Severson; Nathaniel Rothman; Charles F Lynch; Sholom Wacholder; Stephen J Chanock; Thomas M Habermann; Patricia Hartge
Journal:  Blood       Date:  2007-02-27       Impact factor: 22.113

2.  Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene.

Authors:  Rajan P Nair; Philip E Stuart; Ioana Nistor; Ravi Hiremagalore; Nicholas V C Chia; Stefan Jenisch; Michael Weichenthal; Gonçalo R Abecasis; Henry W Lim; Enno Christophers; John J Voorhees; James T Elder
Journal:  Am J Hum Genet       Date:  2006-03-31       Impact factor: 11.025

3.  Clinical and biological relevance of single-nucleotide polymorphisms and acquired somatic mutations of the BCL6 first intron in follicular lymphoma.

Authors:  F Jardin; P Ruminy; F Parmentier; J M Picquenot; M N Courel; P Bertrand; G Buchonnet; H Tilly; C Bastard
Journal:  Leukemia       Date:  2005-10       Impact factor: 11.528

4.  Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma.

Authors:  Wen-Kai Weng; Ronald Levy
Journal:  J Clin Oncol       Date:  2003-09-15       Impact factor: 44.544

5.  A polymorphism in the complement component C1qA correlates with prolonged response following rituximab therapy of follicular lymphoma.

Authors:  Emilian Racila; Brian K Link; Wen-Kai Weng; Thomas E Witzig; Stephen Ansell; Matthew J Maurer; Jian Huang; Christopher Dahle; Ahmad Halwani; Ronald Levy; George J Weiner
Journal:  Clin Cancer Res       Date:  2008-10-15       Impact factor: 12.531

6.  Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma.

Authors:  Silvia Montoto; Andrew John Davies; Janet Matthews; Maria Calaminici; Andrew J Norton; John Amess; Sarah Vinnicombe; Rachel Waters; Ama Z S Rohatiner; T Andrew Lister
Journal:  J Clin Oncol       Date:  2007-05-07       Impact factor: 44.544

7.  Glutathione-S-transferase genotypes influence prognosis in follicular non-Hodgkin's Lymphoma.

Authors:  Stefan Hohaus; Giovanna Mansueto; Giuseppina Massini; Francesco D'Alo; Manuela Giachelia; Maurizio Martini; Luigi Maria Larocca; Maria Teresa Voso; Giuseppe Leone
Journal:  Leuk Lymphoma       Date:  2007-03

8.  The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival.

Authors:  Derville O'Shea; Ciarán O'Riain; Claire Taylor; Rachel Waters; Emanuela Carlotti; Finlay Macdougall; John Gribben; Andreas Rosenwald; German Ott; Lisa M Rimsza; Erlend B Smeland; Nathalie Johnson; Elias Campo; Timothy C Greiner; Wing C Chan; Randy D Gascoyne; George Wright; Louis M Staudt; T Andrew Lister; Jude Fitzgibbon
Journal:  Blood       Date:  2008-07-15       Impact factor: 22.113

9.  Follicular lymphoma international prognostic index.

Authors:  Philippe Solal-Céligny; Pascal Roy; Philippe Colombat; Josephine White; Jim O Armitage; Reyes Arranz-Saez; Wing Y Au; Monica Bellei; Pauline Brice; Dolores Caballero; Bertrand Coiffier; Eulogio Conde-Garcia; Chantal Doyen; Massimo Federico; Richard I Fisher; Javier F Garcia-Conde; Cesare Guglielmi; Anton Hagenbeek; Corinne Haïoun; Michael LeBlanc; Andrew T Lister; Armando Lopez-Guillermo; Peter McLaughlin; Noël Milpied; Pierre Morel; Nicolas Mounier; Stephen J Proctor; Ama Rohatiner; Paul Smith; Pierre Soubeyran; Hervé Tilly; Umberto Vitolo; Pier-Luigi Zinzani; Emanuele Zucca; Emili Montserrat
Journal:  Blood       Date:  2004-05-04       Impact factor: 22.113

10.  Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells.

Authors:  Sandeep S Dave; George Wright; Bruce Tan; Andreas Rosenwald; Randy D Gascoyne; Wing C Chan; Richard I Fisher; Rita M Braziel; Lisa M Rimsza; Thomas M Grogan; Thomas P Miller; Michael LeBlanc; Timothy C Greiner; Dennis D Weisenburger; James C Lynch; Julie Vose; James O Armitage; Erlend B Smeland; Stein Kvaloy; Harald Holte; Jan Delabie; Joseph M Connors; Peter M Lansdorp; Qin Ouyang; T Andrew Lister; Andrew J Davies; Andrew J Norton; H Konrad Muller-Hermelink; German Ott; Elias Campo; Emilio Montserrat; Wyndham H Wilson; Elaine S Jaffe; Richard Simon; Liming Yang; John Powell; Hong Zhao; Neta Goldschmidt; Michael Chiorazzi; Louis M Staudt
Journal:  N Engl J Med       Date:  2004-11-18       Impact factor: 91.245
View more
  6 in total

1.  Risk Factors of Follicular Lymphoma.

Authors:  Shuangge Ma
Journal:  Expert Opin Med Diagn       Date:  2012-05-08

2.  Integrating GWAS and expression data for functional characterization of disease-associated SNPs: an application to follicular lymphoma.

Authors:  Lucia Conde; Paige M Bracci; Rhea Richardson; Stephen B Montgomery; Christine F Skibola
Journal:  Am J Hum Genet       Date:  2012-12-13       Impact factor: 11.025

Review 3.  Transformation in follicular lymphoma: biology, prognosis, and therapeutic options.

Authors:  Eric Wong; Michael Dickinson
Journal:  Curr Oncol Rep       Date:  2012-10       Impact factor: 5.075

4.  A comprehensive evaluation of the role of genetic variation in follicular lymphoma survival.

Authors:  Fredrik Baecklund; Jia-Nee Foo; Paige Bracci; Hatef Darabi; Robert Karlsson; Henrik Hjalgrim; Richard Rosenquist; Hans-Olov Adami; Bengt Glimelius; Mads Melbye; Lucia Conde; Jianjun Liu; Keith Humphreys; Christine F Skibola; Karin E Smedby
Journal:  BMC Med Genet       Date:  2014-10-08       Impact factor: 2.103

5.  NCOA1 is a novel susceptibility gene for multiple myeloma in the Chinese population: A case-control study.

Authors:  Mengle Peng; Guanfei Zhao; Funing Yang; Guixue Cheng; Jing Huang; Xiaosong Qin; Yong Liu; Qingtao Wang; Yongzhe Li; Dongchun Qin
Journal:  PLoS One       Date:  2017-03-06       Impact factor: 3.240

6.  Concordance in survival among first-degree relatives diagnosed with indolent lymphoid malignancies including chronic lymphocytic leukemia.

Authors:  Fredrik Baecklund; Sara Ekberg; Richard Rosenquist; Johan Askling; Sandra Eloranta; Karin E Smedby
Journal:  Eur J Haematol       Date:  2020-09-29       Impact factor: 2.997
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.